T2 colorectal cancers (CRCs) are almost invariably treated by surgical resection, but only 25% have lymph node metastases (LNM). An alternative approach in selected cases
CRCs
CRCs
New Study Suggests T2 Colorectal Cancers Could Be Resected Endoscopically and Analyzed for Risk of Lymph Node Metastases Before Surgical Resection
New Study Suggests T2 Colorectal Cancers Could Be Resected Endoscopically and Analyzed for Risk of Lymph Node Metastases Before Surgical Resection
T1 Colorectal Cancer With Free Resection Margins Between 0.1 and 1 mm: High-Grade Tumor Budding Makes the Difference in Recurrence Risk
T1 Colorectal Cancer With Free Resection Margins Between 0.1 and 1 mm: High-Grade Tumor Budding Makes the Difference in Recurrence Risk
A free resection margin, often interpreted as >1 mm between cancer and the resection line, is an independent predictor of low risk for recurrent cancer
Risks of Recurrence and Mortality After Local Endoscopic Resection of T1 Colorectal Cancer
Risks of Recurrence and Mortality After Local Endoscopic Resection of T1 Colorectal Cancer
In a meta-analysis of 71 studies involving 5167 endoscopically treated T1 colorectal cancers (CRCs), the cumulative recurrence rate was 3.3%, the local recurrence rate was
